Prestige Consumer Healthc...
76.09
0.31 (0.41%)
At close: Jan 15, 2025, 9:35 AM

Prestige Consumer Healthcare Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Dec 31, 2019Sep 30, 2019Jun 30, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
Analgesics Revenue 28.22M 55.82M 30.27M 31.36M 28.50M 29.07M 28.77M 29.46M 28.76M 28.41M 31.45M 29.39M 29.80M 30.10M 32.88M 30.54M 28.65M 88.56M 30.90M 30.38M 27.38M 28.84M 29.86M 25.70M
Analgesics Revenue Growth -49.44% +84.44% -3.49% +10.02% -1.96% +1.07% -2.36% +2.43% +1.22% -9.66% +7.03% -1.38% -1.01% -8.46% +7.68% +6.58% -67.65% +186.57% +1.72% +10.97% -5.08% -3.42% +16.22% n/a
Cough and Cold Revenue 29.27M 52.61M 33.17M 33.23M 29.96M 26.32M 22.72M 31.72M 26.23M 21.39M 33.09M 26.23M 22.02M 26.19M 33.97M 26.27M 22.36M 82.41M 34.16M 29.20M 24.27M 35.76M 30.23M 24.80M
Cough and Cold Revenue Growth -44.36% +58.60% -0.18% +10.91% +13.84% +15.83% -28.37% +20.95% +22.64% -35.38% +26.18% +19.08% -15.91% -22.90% +29.33% +17.47% -72.87% +141.23% +16.99% +20.35% -32.14% +18.28% +21.90% n/a
Dermatologicals Revenue 35.85M 66.85M 27.77M 34.49M 23.88M 28.61M 26.43M 21.98M 25.94M 25.65M 23.30M 26.34M 24.63M 20.04M 20.43M 23.52M 23.37M 64.82M 20.26M 23.81M 20.63M 18.23M 18.15M 11.56M
Dermatologicals Revenue Growth -46.36% +140.73% -19.48% +44.39% -16.53% +8.28% +20.25% -15.28% +1.13% +10.11% -11.57% +6.95% +22.93% -1.90% -13.15% +0.64% -63.95% +219.95% -14.91% +15.41% +13.14% +0.48% +56.97% n/a
Eye and Ear Care Revenue 42.79M 87.48M 45.07M 46.87M 27.25M 25.47M 29.76M 26.52M 27.84M 28.09M 24.84M 25.13M 28.33M 28.40M 26.57M 25.92M 28.80M 82.95M 24.55M 27.74M 28.26M 23.60M 25.43M 25.37M
Eye and Ear Care Revenue Growth -51.09% +94.09% -3.84% +71.97% +7.00% -14.42% +12.25% -4.76% -0.89% +13.11% -1.15% -11.30% -0.26% +6.89% +2.49% -10.00% -65.28% +237.89% -11.51% -1.84% +19.77% -7.22% +0.26% n/a
Gastrointestinal Revenue 60.06M 117.22M 61.63M 52.76M 44.74M 41.24M 38.56M 41.06M 38.48M 38.79M 40.64M 36.46M 36.16M 33.77M 21.81M 22.37M 23.36M 71.67M 22.92M 24.40M 24.13M 24.03M 26.49M 23.54M
Gastrointestinal Revenue Growth -48.76% +90.21% +16.80% +17.93% +8.49% +6.96% -6.09% +6.70% -0.80% -4.56% +11.47% +0.83% +7.08% +54.85% -2.49% -4.25% -67.40% +212.72% -6.09% +1.14% +0.40% -9.29% +12.57% n/a
Oral Care Revenue 24.08M 50.06M 23.46M 22.78M 23.80M 23.50M 22.63M 24.83M 25.87M 24.86M 30.41M 28.09M 27.78M 27.67M 27.21M 27.19M 26.03M 41.00M 10.12M 9.92M 10.17M 12.47M 13.06M 10.26M
Oral Care Revenue Growth -51.89% +113.37% +2.99% -4.26% +1.25% +3.85% -8.87% -4.00% +4.04% -18.24% +8.27% +1.09% +0.41% +1.69% +0.09% +4.46% -36.52% +305.09% +2.02% -2.45% -18.45% -4.51% +27.30% n/a
Other OTC Revenue 3.16M 6.17M 3.11M 2.75M 1.29M 1.26M 1.29M 1.59M 1.35M 1.24M 1.63M 1.28M 1.25M 1.41M 1.39M 1.55M 1.49M 4.54M 1.56M 1.50M 1.42M 1.48M 1.93M 2.94M
Other OTC Revenue Growth -48.85% +98.52% +13.14% +112.95% +2.22% -2.17% -19.12% +17.89% +9.38% -24.20% +27.10% +2.97% -11.43% +1.51% -10.34% +4.03% -67.24% +190.96% +3.65% +6.06% -4.25% -23.05% -34.51% n/a
Women's Health Revenue 60.35M 120.08M 58.27M 62.07M 62.12M 62.58M 62.00M 64.25M 64.88M 65.73M 66.05M 63.34M 66.74M 51.68M 31.48M 33.90M 33.82M 100.77M 34.40M 34.41M 33.61M 31.95M 9.78M n/a
Women's Health Revenue Growth -49.75% +106.09% -6.13% -0.08% -0.74% +0.95% -3.51% -0.97% -1.29% -0.47% +4.27% -5.09% +29.14% +64.19% -7.16% +0.24% -66.43% +192.95% -0.04% +2.39% +5.18% +226.82% n/a n/a

Revenue by Geography

Quarter Mar 31, 2024Mar 31, 2017Mar 31, 2016Mar 31, 2015
North American Otc Healthcare Revenue 958.26M 2.89B 2.63B 2.26B
North American Otc Healthcare Revenue Growth -66.81% +9.62% +16.72% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 67.48M 68.28M 63.98M 65.47M 66.10M 63.92M 58.53M 56.96M 70.26M 66.67M 64.75M 66.22M 72.98M 61.91M 60.24M 59.48M 58.73M 47.68M 63.75M 54.87M 61.18M 56.51M 55.73M 54.99M 61.08M 61.05M 157.13M 57.04M 60.76M 57.28M 70.21M 52.81M 47.39M 47.09M 46.78M 48.07M 44.35M 44.01M 43.05M
Selling, General, and Administrative Revenue Growth -1.17% +6.71% -2.27% -0.95% +3.41% +9.20% +2.77% -18.93% +5.39% +2.97% -2.23% -9.26% +17.88% +2.77% +1.28% +1.27% +23.16% -25.20% +16.19% -10.32% +8.27% +1.39% +1.35% -9.97% +0.04% -61.15% +175.47% -6.11% +6.07% -18.42% +32.94% +11.45% +0.63% +0.66% -2.68% +8.38% +0.78% +2.23% n/a
Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales and Marketing Revenue 41.41M 39.37M 37.52M 39.47M 40.10M 36.23M 30.87M 30.42M 43.82M 39.95M 36.94M 40.24M 40.73M 39.44M 36.42M 38.08M 38.34M 27.75M 40.17M 33.56M 38.67M 34.80M 34.43M 34.50M 37.04M 37.11M 35.32M 35.84M 39.19M 36.94M 41.45M 30.68M 28.59M 27.64M 26.55M 29.93M 27.89M 26.42M 25.37M
Sales and Marketing Revenue Growth +5.19% +4.93% -4.94% -1.59% +10.68% +17.37% +1.46% -30.57% +9.68% +8.17% -8.21% -1.21% +3.27% +8.30% -4.37% -0.68% +38.17% -30.91% +19.69% -13.21% +11.11% +1.07% -0.21% -6.85% -0.19% +5.07% -1.44% -8.56% +6.07% -10.87% +35.10% +7.31% +3.46% +4.08% -11.30% +7.32% +5.57% +4.16% n/a